Novartis AG
- Country
- ๐จ๐ญSwitzerland
- Ownership
- Public, Private
- Established
- 1996-01-01
- Employees
- 76K
- Market Cap
- $242.6B
- Introduction
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
Real-world Aliskiren Use in Diabetic Patients
- Conditions
- DiabetesHypertension
- First Posted Date
- 2011-07-13
- Last Posted Date
- 2011-07-14
- Lead Sponsor
- Novartis
- Target Recruit Count
- 200
- Registration Number
- NCT01393860
- Locations
- ๐บ๐ธ
MODEL Clinical Research, Research Division of Bay Endocrinology Associates GBMC Physicians pavilion North, Baltimore, Maryland, United States
Efficacy and Safety of Diclofenac 1.16% Gel in Subjects With Acute Neck Pain
- Conditions
- Neck Pain
- Interventions
- Drug: Placebo gel
- First Posted Date
- 2011-04-14
- Last Posted Date
- 2012-07-18
- Lead Sponsor
- Novartis
- Target Recruit Count
- 72
- Registration Number
- NCT01335724
- Locations
- ๐ฉ๐ช
NCH investigative site, Munich, Germany
Drug Use Investigation for TYKERB Tablet (All Case Investigation)
- First Posted Date
- 2011-04-11
- Last Posted Date
- 2017-04-26
- Lead Sponsor
- Novartis
- Target Recruit Count
- 4054
- Registration Number
- NCT01332396
Efficacy of DNK333 in Patients With COPD and Cough
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: PlaceboDrug: DNK333 100 mg twice daily
- First Posted Date
- 2011-02-01
- Last Posted Date
- 2011-02-01
- Lead Sponsor
- Novartis
- Target Recruit Count
- 28
- Registration Number
- NCT01287325
- Locations
- ๐ฌ๐ง
Novartis Investigative Site, London, United Kingdom
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
- First Posted Date
- 2011-01-24
- Last Posted Date
- 2012-09-06
- Lead Sponsor
- Novartis
- Target Recruit Count
- 64
- Registration Number
- NCT01281657
- Locations
- ๐บ๐ธ
Caritas St. Elizabeth's Hospital, Boston, Massachusetts, United States
๐บ๐ธSwedish Neuroscience Institute, Seattle, Washington, United States
๐บ๐ธUniversity of Miami, Miami, Florida, United States
Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Ankle Sprain
- First Posted Date
- 2011-01-10
- Last Posted Date
- 2013-01-24
- Lead Sponsor
- Novartis
- Target Recruit Count
- 205
- Registration Number
- NCT01272934
- Locations
- ๐ฉ๐ช
NCH investigative site, Gilching, Germany
๐ฉ๐ชNCH investigative site, Munich, Germany., Munich, Germany
Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Blunt Trauma Injuries
- Conditions
- Acute Blunt Soft Tissue Injuries/Contusions
- Interventions
- Other: Placebo
- First Posted Date
- 2011-01-10
- Last Posted Date
- 2013-01-10
- Lead Sponsor
- Novartis
- Target Recruit Count
- 204
- Registration Number
- NCT01272947
- Locations
- ๐ฉ๐ช
NCH investigative site, Munich, Germany
Efficacy and Safety of a Sore Throat Lozenge Containing Lidocaine and Cetylpyridinium Chloride in Patients With Sore Throat Due to a Common Cold.
- Conditions
- Sore Throat Due to a Common Cold
- Interventions
- First Posted Date
- 2010-12-23
- Last Posted Date
- 2013-04-24
- Lead Sponsor
- Novartis
- Target Recruit Count
- 250
- Registration Number
- NCT01265446
- Locations
- ๐ฉ๐ช
Socratec, Erfurt, Germany
A Community Setting Study of Malaria After Systematic Treatment of Symptomatic Carriers of P. Falciparum With COA566 (Coartemยฎ)
- First Posted Date
- 2010-12-08
- Last Posted Date
- 2014-02-10
- Lead Sponsor
- Novartis
- Target Recruit Count
- 14075
- Registration Number
- NCT01256658
- Locations
- ๐ง๐ซ
Novartis Investigative site, Ouagadougou, Burkina Faso
๐ง๐ซNovartis Investigative Site, Burkina Faso, Burkina Faso
๐ง๐ซCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso
Pharmacokinetics of Generic to Brand Tacrolimus in Stable Renal Transplant Patients
- Conditions
- Renal Transplant
- Interventions
- First Posted Date
- 2010-12-08
- Last Posted Date
- 2012-06-21
- Lead Sponsor
- Novartis
- Target Recruit Count
- 71
- Registration Number
- NCT01256294
- Locations
- ๐บ๐ธ
University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States
๐บ๐ธUniversity of Cincinnati Medical Center, Cincinnati, Ohio, United States